A team led by biologists at the University of California, San Diego has discovered a molecule in roundworms that makes 
them susceptible to Bacillus thuringiensis toxin, or Bt toxin-a pesticide produced by bacteria and widely used by organic 
farmers and in genetically engineered crops to ward off insect pests. 
Their findings should facilitate the design and use of Bt toxins to prevent insects, which the researchers believe also 
possess the molecule, from developing resistance to Bt, extending the life of this natural pesticide. 
The study, published February 11 in the journal Science, details the structure of a molecule to which Bt attaches, or 
"binds," in the lining of the intestines of insects and roundworms. The molecule is a glycolipid-a lipid attached to a 
tree-like arrangement of sugars. Because changes in the sugars impact Bt's ability to bind, the researchers believe that 
their discovery will make it possible to develop better pesticides and lead to new treatments for parasitic infections that 
affect close to two billion people worldwide. 
"Our previous findings with the roundworm C. elegans strongly suggested that specific sugar structures are likely critical 
for Bt toxin susceptibility," said Joel Griffitts, the first author on the paper and a former graduate student with UCSD 
biology professor Raffi Aroian. "This latest paper demonstrates what these sugars actually do. They provide a receptor for 
the toxin that allows the toxin to recognize its "victim"-a roundworm or an insect. This paper also brings us from the 
conceptual realm to the chemical nature of these sugar structures-how their atoms are arranged, and how the toxin binds to 
them." 
"Bt toxin, which is produced by a soil bacterium, is toxic to insects and roundworms, but not to vertebrates, which accounts 
for its popularity as a pesticide," explained Aroian, who led the team. "But the development of insect resistance to Bt is a 
major threat to its long term use. Our findings make it possible to understand resistance at the molecular level and should 
improve resistance management." 
In collaboration with Paul Cremer and Tinglu Yang, coauthors on the paper and chemists at Texas A&M University, Griffitts and 
Aroian found that Bt toxin directly binds glycolipids. However, in each of the four Bt resistant mutants tested-bre-2, bre-3, 
bre-4 and bre-5-the researchers found that there was either zero or dramatically reduced binding of glycolipids to Bt toxin. 
They concluded that the defective sugar structure of the glycolipid receptor in each of the mutants prevents Bt from binding. 
Other members of the research team, coauthors Stuart Haslam and Anne Dell, biologists at Imperial College London; Barbara 
Mulloy, a biochemist at the Laboratory for Molecular Structure, National Institute for Biological Standards and Control in 
Hertfordshire, England; and Howard Morris, a biochemist at the M-SCAN Mass Spectrometry Research and Training Centre in 
Berkshire England, determined the chemical structure of the normal glycolipid receptor that binds Bt toxin. 
									
									
									
Elements of this structure are found in both insects and nematodes, but are not found in vertebrates at all, which may be one 
reason these proteins are safe to vertebrates. This work furthermore opens up the possibility of using Bt toxins against 
roundworms that parasitize humans. 
"These parasites infect nearly one-third of the human population and pose a significant health problem in developing 
countries," said Aroian. "Perhaps one-day vertebrate-safe Bt toxins could be used as human therapies against these 
parasites." 
Griffitts and Aroian credit the flexibility of the roundworm C. elegans as an experimental system, particularly the ease of 
manipulating it genetically, in making it possible to find and characterize the structure of the long sought-after Bt 
receptor. However, their results apply to insects as well. Michael Adang and Stephan Garczynski, coauthors and entomologists 
at the University of Georgia, showed that the glycolipid receptor is present in the tobacco hornworm, an insect pest that is 
susceptible to Bt toxins used commercially in plants. 
"It will now be possible to monitor insect populations near fields where Bt is used and catch insect resistance in its early 
stages by looking for changes in glycolipids," said Aroian. "If changes are detected, switching to another pesticide, perhaps 
even another variety of Bt that works through a different mechanism, could prevent the resistance genes from becoming 
widespread." 
According to the researchers, prior work indicates that there are other receptors that also contribute to Bt resistance. 
Combining pesticides that work through different receptors or designing pesticides that can work through more than one 
receptor type could thwart the development of resistance. 
"This paper presents an intriguing question," said Griffitts. "In light of findings by insect biologists that certain 
proteins function as important Bt toxin receptors in some cases, how might glycolipid and protein receptors cooperate to 
engage this intoxication program? If the field can figure this out, it might allow for the engineering of toxins that can 
utilize either type of receptor alternatively, such that host resistance would require the mutation of both receptor types. 
This means that resistance would be exponentially less probable." 
The study was funded by the National Science Foundation, the Burroughs-Wellcome Foundation and the Beckman Foundation. 
Comment: Raffi Aroian (858) 822-1396 
Sherry Seethaler - sseethalerucsd
University of California - San Diego
Комментариев нет:
Отправить комментарий